SCHEMBL8964697

SCHEMBL8964697

C=C(F)Cc1ccc(O)c(C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 0.61
ESR2 Q92731 8/20 0.61
TDP1 Q9NUW8 3/20 0.45
TP53 P04637 1/20 0.45
AR P10275 4/20 0.42
PDE10A Q9Y233 1/20 0.42
DBH P09172 1/20 0.41
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
HIF1A Q16665 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GAA P10253 2/20 0.38
TSHR P16473 2/20 0.38
NFKB1 P19838 2/20 0.38
RGS12 O14924 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17748387 0.84 ESR1 (0.61) ESR1ESR2TDP1TP53AR
SCHEMBL8964689 0.81 KDM4E (0.57) ESR1TDP1TP53ARPTGS1
SCHEMBL13176793 0.78 ESR1 (0.53) ESR1ESR2TDP1TP53AR
SCHEMBL28492275 0.78 ESR1 (0.63) ESR1ESR2TDP1TP53AR
SCHEMBL8964628 0.78 CYP17A1 (0.42) ESR1ESR2TDP1TP53DBH
SCHEMBL27829497 0.77 ESR1 (0.68) ESR1ESR2TDP1TP53AR
SCHEMBL12450026 0.77 ESR1 (0.68) ESR1ESR2TDP1TP53AR
SCHEMBL29720481 0.76 ESR1 (0.74) ESR1ESR2TDP1TP53AR
SCHEMBL36509 0.76 ESR1 (1.00) ESR1ESR2TDP1TP53AR
SCHEMBL29357262 0.76 ESR1 (1.00) ESR1ESR2TDP1TP53AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0410379-B1 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMA (US) 1996-01-31 EP disclosed
US-5068465-A Hypotensive agents or enzyme inhibitors for treatment of hypertension MERRELL DOW PHARMACEUTICALS INC. (US) 1991-11-26 US disclosed
EP-0410379-A2 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP disclosed
EP-0410380-A2 Novel process for the synthesis of 2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP disclosed
US-4981868-A ENZYME INHIBITORS, HYPOTENSIVES MERRELL DOW PHARMACEUTICAL (US) 1991-01-01 US disclosed